Home Up Contents Euro Prices Order Info Distributors

 T4 Thyroxine ELISA

GENTAUR Belgium : + 32 2 7325688 France : 01 43250150 Italy : 02 36006593 • Germany : +49 241 6085 13140

Up

 

TEL: +32 16 58 90 45

Fax :+ 32 16 50 90 45

GENTAUR Europe

tel+32 2 732 5688
fax+32 2 732 4414
info@genprice.com
Av. de l' Armée 68
B-1040 BRUSSELS
BELGIUM

GENTAUR France

tel 01 43 25 01 50

fax01 43 25 01 60

9, rue Lagrange

75005 PARIS

FRANCE

GENTAUR Italy

tel 02 36 00 65 93

fax 02 36 00 65 94

20135 MILANO

ITALY

GENTAUR Germany

tel +49 241 6085 13140

fax +49 241 6085 33033

Forckenbeckstraße 6,

D-52074 Aachen

GERMANY


 

EK-34A051101

FT4 ELISA KIT

(REF: EK-34)

475 Euro

The FT4 ELISA system provides quantitative in vitro determination of free thyroxine (FT4) in human serum. FT4 can be assayed in the range of 0-100 pmol/l (0-7.77 ng/ml) using 25 µl serum samples.

Introduction

Circulating thyroid hormones (thyroxin, T4 and triiodothyronine, T3) are distributed into two, a major, protein-bound, and a minor, (0.03 % of T4 and 0.3 % of T3) free fractions. Variations in total thyroid hormone in blood may result from either changes of binding proteins concentrations, or thyroid hormone production. Thyroid disorders are existing only if a net change of free unbound fractions occur persistently. Therefore the clinical utility of total T4 and T3 is dependant on the knowledge of functional levels of binding proteins.

Serum level of free T4 (FT4) correlates very well with secretion and metabolism rate of T4, and has been recommended as the most reliable and meaningful diagnostic indicator of thyroid diseases, mostly in conflicting or borderline instances. Apparent FT4 levels, however, are very sensitive to the analytical method due to the sophisticated multiple equilibrium between various protein compartments of T4.

Principle of method

This assay is based on the competition between FT4 present in standards and samples - and conjugate (enzyme-T4) for a limited number of binding sites on anti-thyroxin antibodies. After the completion of the required incubation period, the antibody bound enzyme-conjugate is separated from the unbound enzyme-conjugate by aspiration or decantation. The activity of the enzyme present on the surface of the well is quantitated by reaction with a suitable substrate to produce colour.

After the addition of a ready-to-use tetramethyl-benzidine (TMB) / peroxide substrate the signal is measured in an ELISA photometer at 450 nm wavelength.

The concentration of antigen is directly proportional to the optical density measured in the wells. The unknown concentration of FT4 in patient samples is read of a calibration curve constructed by plotting binding values against a series of calibrators containing known amounts of FT4.

Contents of the kit

1. 1 bottle CONJUGATE (5.5 ml), ready to use, containing a solution of thyroxine conjugated to horseradish peroxidase in buffer.

Do not expose to direct sunlight!

Store unopened at 2-8 °C until expiration date. Store opened bottle at 2-8 °C for up to 60 days.

2. 6 vials STANDARD (6 x 0.5 ml), ready to use, containing 0 (S1), 6 (S2), 12 (S3), 25 (S4), 50 (S5) 100 (S6) pmol/l in human serum with 0.1 % NaN3.

(1 pmol/l = 0.0777 ng/dl)

Store unopened at 2-8 °C until kit expiration date. Store opened vials at 2-8 °C for up to 60 days.

3. 1 vial CONTROL SERUM (0.5 ml),

lyophilised human serum with 0.1% NaN3.

The concentration of the control serum is specified in the quality certificate enclosed.

Store unopened at 2-8 °C until kit expiration date.

See Preparation of reagents.

4. 1 bottle SUBSTRATE (25 ml) ready to use, in brown plastic bottle. Do not expose to direct light!

Store unopened at 2-8 °C until expiration date. Store opened bottle at 2-8 °C for up to 60 days.

5. 1 piece MICROTITER PLATE, ready to use. 12 strips, packed in an air-tight foil.

Store at 2-8 °C until expiration date.

6. 1 bottle WASH BUFFER CONCENTRATE (20 ml), 0.01 % merthiolate.

Store at 2-8 °C until expiration date.

See Preparation of reagents.

7. 1 bottle STOP REAGENT (6 ml) ready ro use, 1M sulfuric acid

Store at 2-8 °C until expiration date.

Plate map

Quality certificate

Pack leaflet

Plastic foil

Materials, tools and equipment required

Precision pipettes with disposable tips (25, 50, 100, 200 and 300 µl), distilled water, vortex mixer, shaker, plastic tray, absorbent tissue, ELISA photometer

Recommended tools and equipment

Repeating pipettes, multi-channel ELISA pipettes

Specimen collection and storage

Serum samples can be prepared according to common procedures used routinely in clinical laboratory practice. Samples can be stored at 2-8 °C if the assay is carried out within 24 hours, otherwise aliquots should be prepared and stored deep frozen (-20°C). Frozen samples should be thawed and thoroughly mixed before assaying. Repeated freezing and thawing should be avoided. Do not use lipemic, hemolyzed or turbid specimens.

Preparation of reagents, storage

Add the wash buffer concentrate (20 ml) to 600 ml distilled water to obtain 620 ml wash solution. Upon dilution store at 2-8°C for up to 60 days.

Add 500 µl distilled water to the lyophilised control serum. Mix gently with shaking or vortexing (foaming should be avoided). Ensure that complete dissolution is achieved, and allow the solution to equilibrate at room temperature for at least 20 minutes. Store at 2-8°C for up to 60 days.

The actual expiry date of the kit is given on the package label and in the quality certificate.

CAUTION!

Equilibrate all reagents and serum samples to room temperature. Mix all reagents and samples thoroughly before use. Avoid excessive foaming.

Assay procedure

(For a quick guide , refer to Table 1.)

1. Equilibrate reagents and samples to room temperature before use. Homogenize all reagents and samples by gentle mixing to avoid foaming.

2. Label the plate map for duplicates of each standards (S1-S6), control serum (C) and samples (SX).

3. Pipette 25 µl each of standards, control serum and samples into the appropriate wells.

4. Pipette 50 µl of conjugate solution into each well by the multi-channel pipette.

5. Pipette 100 µl antiserum into each well by the multi-channel pipette. Cover the plate by the enclosed foil, shake it on the shaker for 1 hour at RT (20-26 °C).

6. Remove the cover and pour the liquid directly over the lab sink. Holding in the upside down position place the plate immediately on an absorbent tissue. Pay special attention to crossing-over between wells due to droplets backflow.

7. Add 300 µl wash buffer into each well, decant (tap and blot) or aspirate. Repeat this step 5 times.

An automatic or manual plate washer can be used. Follow manufacturer’s instruction for proper usage.

8. Pour the substrate into its plastic tray, and pipette 200 µl to each well with the aid of the multi-channel pipette. Place the plate into the dark for 30 minutes. (If less than the whole volume is used in one assay, do not pipette directly from the bottle, and never fill the unused reagent back into its original bottle).

9. Pipette 50 µl stop reagent into each well, and shake gently.

10. Measure in the ELISA photometer at 450 nm.

11. Calculate the concentrations of the samples as described in Calculation of results.

Table 1. Assay Protocol, Pipetting Guide (all volumes in microlitres)

 

Tubes Standard Control Sample
Standard 25
Control 25
Sample 25
Conjugate 50 50 50
Antiserum 100 100 100
Shake for 1 hour at room temperature
Decant the fluid and blot on filter paper
Wash buffer 300 300 300
Decant the fluid and blot on filter paper
Repeat the washing step 5 times
Substrate 200 200 200
30 minutes at room temperature
Stop reagent 50 50 50
Measurement
Calculate the results
 

Calculate the average OD for each pair of duplicates. Draw the standard curve on a lin-lin graph paper by plotting calculated OD of each standard level (ordinate) against the respective concentration (abscissa). Obtain sample values by interpolation of sample OD on the standard curve.

Specific binding values can be calculated for each standard and sample according to the following equation:

100)()(,,,%/1620×-=ODSODSCSSBBxTable 2. Typical assay data

 

  OD OD mean B/B0, %
S1 2.1798

2.3001

2.2399  
S2 1.5763

1.5724

1.5743 70.2
S3 1.1950

1.1184

1.1567 51.6
S4 0.7820

0.7335

0.7577 33.8
S5 0.3938

0.3905

0.3921 17.5
S6 0.1649

0.1719

0.1684 7.5
C 1.0873

1.0351

1.0612 35.3
 

 

00,511,522,50102030405060708090100Figure 1: A typical standard curve (Do not use to calculate unknown samples!)

Characterization of assay

Typical assay parameters

Maximum Absorbance (S1 OD) > 1.2

Sensitivity

For the analytical sensitivity 2.15 pmol/l has been obtained by assaying 15 replicates of the zero standard. The sensitivity has been determined as the concentration corresponding to the sum of the mean OD and its double standard deviation. As

Specificity

T3 and rT3 were added in 5 different concentrations to T4 free standard (S1=B0) and the concentration of FT4 was measured. The cross reactivity are shown below.

 

T3 added

(nmol/l)

FT4

measured (pmol/l)

r-T3

added (nmol/l)

FT4

measured (pmol/l)

1 < DL 1 < DL
10 0.1 10 0.3
100 0.7 100 2.6
500 3.2 500 13.5
1000 6.1 1000 25.8
 

DL – detection limit

Precision

7 patient samples were assayed in 15 replicates to determine intra-assay precision. Values obtained are shown below.

 

Sample Number of replicates Mean value CV%
1 15 4.1 18.8
2 15 10.9 7.8
3 15 14.6 7.1
4 15 19.1 5.5
5 15 26.8 2.9
6 15 35.1 4.4
7 15 41.3 3.8
 

 

Reproducibility

To determine inter-assay precision 7 samples were measured in duplicates in 10 independent assays by 3 operators using different kit batches. Values obtained are shown below.

 

Sample Number of runs Mean value CV%
1 10 7.32 12.8
2 10 13.20 7.36
3 10 14.13 7.62
4 10 14.72 7.74
5 10 28.46 4.64
6 10 41.52 6.43
7 10 51.61 5.35
 

 

Recovery

Recovery was defined as the measured increase expressed as per cent of expected increase upon spiking serum samples with known amount of T4. 85.3 ± 5.9 % (mean ± SD) was obtained for 5 samples.

Expected Values

It is recommended that each laboratory establish its own reference intervals. The expected values presented here are based on testing of apparently healthy blood donors. Samples were measured in duplicates using different kit lots.

In a population (n=199) of adult female and male blood donors (ages: mean 38.09 ± 10.02, range 17 - 61) serum concentrations of FT4 were 15.6 ± 2.07 pmol/l (mean ± SD).

a guide (mean ± 2*SD), 11.4 – 19.7 pmol/l reference range was obtained from normal patients based on statistical consideration only. Taking into consideration not only statistical results but clinical practice as well, a more realistic reference range can be recommended 10-22 pmol/l.

Procedural notes

A thorough understanding of this package insert is necessary for successful use of the kit. Reliable results will only be obtained by using precise laboratory techniques and accurately following the package insert.

Use a clean disposable pipette tip for each reagent, Standards, Control or specimen.

Pipetting of samples should not extend beyond 10 minutes to avoid assay drift.

Always add reagents in the same order to minimize reaction time differences between wells.

The wash procedure is critical. Insufficient washing will result in poor precision and falsely elevated absorbance readings.

Avoid microbial contamination of reagents, especially of the Conjugate solution and TMB substrate:

-Do not leave the cap off of the storage bottle for prolonged periods of time.

-Never pipette directly from the bottle. Always pour just the necessary volume into a separate container for use then discard the excess after use.

The results should be read within 30 minutes of adding the Stop solution.

Additional information

Components from various lots or from kits of different manufacturers should not be mixed or interchanged.

Biohazard

Human blood products used in the kit have been obtained from healthy human donors. They were tested individually by using approved methods (EIA, enzyme immunoassay), and were found to be negative, for the presence of both Human Immunodeficiency Virus antibody (Anti-HIV-1) and Hepatitis B surface Antigen (HBsAg).

Care should always be taken when handling human specimens to be tested with diagnostic kits. Even if the subject has been tested, no method can offer complete assurance that Hepatitis B Virus, Human Immunodeficiency Virus (HIV-1), or other infectious agents are absent. Human blood samples should therefore be handled as potentially infectious materials.

 

  Use by   Control
  Batch code   Standard
  Caution, consult accompanying documents   Coated plate
  Biological risk   Conjugate
  Consult operating instructions   Wash buffer
  In vitro diagnostic medical device   Substrate
  Manufacturer   Stop reagent
Catalogue number Antiserum
  Temperature limitation

Store between 2-8oC

 
 

© 2005 GENTAUR bvba
 

Bioxys, HIV p24, TNF a, IFN gamma, Agarose